Stiolto Respimat 2.736 ug/1

Stiolto Respimat 2.736 µg/1 is a combination inhaler containing tiotropium bromide and olodaterol. It is designed for respiratory use to help manage chronic obstructive pulmonary disease (COPD) symptoms. This metered spray delivers precise doses for effective inhalation therapy.

Stiolto Respimat 2.736 µg/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It combines two active ingredients, tiotropium bromide and olodaterol, to help improve lung function and reduce symptoms such as wheezing, shortness of breath, and coughing. This medication is often prescribed for individuals with COPD to enhance breathing and overall respiratory health.

Common effects of Stiolto Respimat 2.736 µg/1 may include improved breathing and reduced symptoms of COPD. Some users might experience side effects such as dry mouth, throat irritation, or headaches. It is important to follow the prescribed usage guidelines to minimize potential adverse effects.

Stiolto Respimat 2.736 µg/1 should be used as directed by a healthcare professional. It is important to store the inhaler properly and keep it out of reach of children. Users should be aware of potential allergies to the ingredients and consult a healthcare provider if any severe reactions occur.

Stiolto Respimat 2.736 µg/1 may interact with other medications, including beta-blockers, anticholinergics, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be moderated while using this inhaler.